CD274 and gastric cancer: PLGA-PEG nanoparticles have been used to encapsulate circRNA inhibitors, protecting them from enzymatic degradation and improving tumor accumulation in gastric cancer models, where they successfully reduced PD-L1 expression and enhanced T cell–mediated killing.